← Leaderboards
Russell Elliott Poland
La Biomed Res Inst/ Harbor Ucla Med Ctr
$3,175,544
Attributed
$3,175,544
Total exposure
9
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$3,175,544 · 9
By mechanism
R01$1,378,204 · 3
M01$955,840 · 4
R21$841,500 · 2
Top collaborators
No co-investigators on record.
Most similar at La Biomed Res Inst/ Harbor Ucla Med Ctr
Same institution · by research overlap
- Michael Glenn Ross$10,022,584
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchDrug Adverse EffectPsychopharmacologyHuman Therapy EvaluationRacial /Ethnic DifferencePharmacokineticsAfrican AmericanMental Disorder ChemotherapyOutcomes ResearchCaucasian AmericanAntidepressantsCytochrome P450PharmacogeneticsDrug MetabolismNeuroendocrine SystemLaboratory RatBehavioral /Social Science Research TagPatient Oriented ResearchNicotineAnticholinergic AgentBioperiodicityFenfluramineDrug Screening /Evaluation
Grant awards (25)
Ethnic Variations in Antidepressant Response$229,500
R01 · FY2003 · MH
Developmental Exposure to Nicotine$153,000
R21 · FY2003 · DA
Ethnic Variations in Antidepressant Response$229,500
R01 · FY2002 · MH
Treatment of Depression with Massage in End of Life AIDS$191,250
R21 · FY2002 · AT
Developmental Exposure to Nicotine$153,000
R21 · FY2002 · DA
NEURODEVELOPMENTAL INSULTS AND SCHIZOPHRENIA$293,202
R01 · FY2001 · MH
CHRONOENDOCRINOLOGY OF SLEEP DISTURBANCES IN DEPRESSION$237,978
M01 · FY2001 · RR
NICOTINE PHARMACOGENETICS--INFLUENCE OF ETHNICITY$237,978
M01 · FY2001 · RR
BUPROPION SR ON SLEEP$237,978
M01 · FY2001 · RR
PHARMACOKINETICS OF REBOXETINE IN HEALTHY VOLUNTEERS W/ DIFFERENT ETH$237,978
M01 · FY2001 · RR
Ethnic Variations in Antidepressant Response$229,500
R01 · FY2001 · MH
Treatment of Depression with Massage in End of Life AIDS$191,250
R21 · FY2001 · AT
Developmental Exposure to Nicotine$153,000
R21 · FY2001 · DA
NEURODEVELOPMENTAL INSULTS AND SCHIZOPHRENIA$283,740
R01 · FY2000 · MH
CORE--LABORATORY$112,762
R01 · FY2000 · MH
BUPROPION SR ON SLEEP$982
M01 · FY2000 · RR
PHARMACOKINETICS OF REBOXETINE IN HEALTHY VOLUNTEERS W/ DIFFERENT ETH$982
M01 · FY2000 · RR
CHRONOENDOCRINOLOGY OF SLEEP DISTURBANCES IN DEPRESSION$982
M01 · FY2000 · RR
NICOTINE PHARMACOGENETICS--INFLUENCE OF ETHNICITY$982
M01 · FY2000 · RR
PHARMACOKINETICS OF REBOXETINE IN HEALTHY VOLUNTEERS W/ DIFFERENT ETH$0
M01 · FY2000 · RR
CHRONOENDOCRINOLOGY OF SLEEP DISTURBANCES IN DEPRESSION$0
M01 · FY2000 · RR
PHARMACOKINETICS OF REBOXETINE IN HEALTHY VOLUNTEERS W/ DIFFERENT ETH$0
M01 · FY2000 · RR
BUPROPION SR ON SLEEP$0
M01 · FY2000 · RR
CHRONOENDOCRINOLOGY OF SLEEP DISTURBANCES IN DEPRESSION$0
M01 · FY2000 · RR
BUPROPION SR ON SLEEP$0
M01 · FY2000 · RR